Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

King Merger With Jones Will Support Altace Marketing To Diabetic Patients

Executive Summary

King Pharmaceuticals' merger with Jones Pharma will provide support for marketing of King's ACE inhibitor Altace to diabetic patients, the company indicated.

You may also be interested in...



Novavax To Increase Sales Force To 100; Will Co-Promote Estrasorb With King

Novavax plans to ramp up its sales force from 65 reps to 100 reps in preparation for the launch of its estrogen replacement cream Estrasorb.

Novavax To Increase Sales Force To 100; Will Co-Promote Estrasorb With King

Novavax plans to ramp up its sales force from 65 reps to 100 reps in preparation for the launch of its estrogen replacement cream Estrasorb.

Altace Will Gain 1,000 Wyeth Reps Through Copromotion Deal

Wyeth-Ayerst is allocating approximately 1,000 sales reps to promote King's Altace in the U.S. and Puerto Rico, under a copromotion agreement announced June 23.

UsernamePublicRestriction

Register

IV001392

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel